期刊文献+

系统性疾病相关ILD患者血清CEA水平与疾病严重程度及预后的相关性

Correlation of serum CEA levels with severity and survival of systemic disease-related interstitial lung disease(ILD)
下载PDF
导出
摘要 目的研究血清癌胚抗原(CEA)在系统性疾病相关的间质性肺病(ILD)患者中的表达情况,及其与疾病严重程度及预后的相关性。方法收集80例系统性疾病相关ILD患者,并设立对照组,统计血清CEA水平,并将血清CEA水平与疾病严重程度指标进行Pearson相关分析,最后采用Kaplan-Meier生存分析及Cox回归分析评估血清CEA水平对1年生存率的影响。结果病例组血清CEA水平明显升高,血清CEA水平与ILD严重程度指标均相关,并与1年生存率显著相关(均P<0.05)。结论血清CEA水平是评估系统性疾病相关ILD病情及预后有较好相关性的血清学指标。 Objective To investigate the correlation of serum carcinoembryonic antigen (CEA) levels with the severity and survival of systematic disease-related interstitial lung disease (ILD). Methods Serum CEA levels were measured by mi- croparticle enzyme immunoassays (Abbott kits and AxSYM system in 80 patients with ILD and 80 healthy subjects. Correlation of serum CEA levels with pulmonary function (DLco % and FVC% and OI) was evaluated by Pearson's correlation; that with fibrosis score on HRCT was analyzed by Spearman's correlation. Survival curve of patients was generated using Kaplan-Meier method, equality of survival distributions was tested using log-rank testing, univariate and multivariate Cox regression analyses. Results Serum CEA levels were higher in ILD patients than those in controls(P〈0.05), were correlated with DLco%, FVC%, OI and fibrosis score on HRCT(P〈0.05). Serum CEA levels were negatively correlated with 1-y survival of patients(P〈0.05). Univariate and mul- tivariate Cox regression analysis demonstrated that serum CEA was an independent predictor of survival (HR=1.847, P=0.000). Conclusion Serum CEA can be a cost-effective and convenient marker to evaluate disease severity, survival and prognosis of patients with systemic disease-related ILD.
出处 《浙江医学》 CAS 2015年第11期937-940,共4页 Zhejiang Medical Journal
关键词 癌胚抗原 间质性肺病 结缔组织病 预后 Carcinoembryonic antigen Interstitial lung disease Connective tissue disease Prognosis
  • 相关文献

参考文献10

  • 1Mosca M, Tani C, Vagnani S, et al. The diagnosis and classifica- tion of undifferentiated connective tissue diseases[J].J Autoimmun, 2014,48-49:50-52.
  • 2Bergamaschi S, Morato E, Bazzo M, et al. Tumor markers are el- evated in patients with rheumatoid arthritis and do not indicate presence of cancer[J]. Int J Rheum Dis, 2012, 15(2):179-182.
  • 3Fahim A, Crooks M G, Wilmot R, et al. Serum carcinoembryonic antigen correlates with severity of idiopathic pulmonary fibrosis [J]. Respirology, 2012, 17(8):1247-1252.
  • 4Corte T J, Copley S J, Desai S R, et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia[J], Eur Respir J, 2012, 39: 661-668.
  • 5Kreuter M, Ehlers-Tenenbaum S, Schaaf M, et al. Treatment and outcome of lung cancer in idiopathic interstitial pneumonias[J]. SarcoidosisVasc Diffuse Lung Dis, 2015, 31(4):266-274.
  • 6Khan K A, Kennedy M P, Moore E, et al. Radiological character- istics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis[J]. Lung, 2015, 193(1):71-77.
  • 7Vancheri C, Failla M, Crimi N, et al. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology[J]. Eur- Respir J, 2010, 35: 496-504.
  • 8Koo B S, Hong S, Kim Y J, et al. Mortality in patients with rheuma- toid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent[J]. Korean J Intern Med, 2015, 30(1):104-109.
  • 9Navaratnam V, All N, Smith C J, et al. Does the presence of con- nective tissue disease modify survival in patients with pulmonary fibrosis?[J]. Respir Med, 2011, 105(12):1925-1930.
  • 10Margaritopoulos G A, Romagnoli M, Poletti V, et al. Recent ad- vances in the pathogenesis and clinical evaluation of pulmonary fibrosis[J]. EurRespir Rev, 2012, 21(123):48-56.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部